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↑What is “already known” in this topic: 
Hospital infections have affected millions of people around the 
world and are considered as one of the most important issues 
related to patient safety.   
→What this article adds: 
Nosocomial infection increases the length of hospital stay up to 
25 days. In addition, in this study, it was found that infected 
and non-infected patients stayed 15.8±17.2 and 40.8±19.1 days 
in the hospital, respectively. Furthermore, the total cost of pa-
tients without any hospital infection was 2451±3098 USD (83 
674 480 ± 105 765 500 Rials) and that of the infected patients 
was 3264 ±6078 USD (111 430 700±207 497 500 Rials).  
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Abstract 
    Background: Hospital infections have affected millions of people around the world and are considered as one of the most important 
issues related to patient safety. Therefore, this study was conducted to estimate the extra costs caused by hospital-acquired infections in 
hospitals. 
   Methods: This retrospective cohort study was conducted in Tehran province, Iran, in 2017. Medical records of 235 patients hospital-
ized in one of Tehran hospitals were reviewed for the study.  They were divided into case (90 patients) and control (145 patients) 
groups. Data were analyzed using SPSS and STATA software. 
   Results: Results revealed no significant relationship between age and gender with the incidence of nosocomial infection (p>0.05).  
However, the chance of nosocomial infection is most affected by length of hospital stay and costs paid by patients. Moreover, noso-
comial infection increases the length of hospital stay up to 25 days.  Our results revealed that the mean±SD hospital stay of infected 
and non-infected patients were 15.8±17.2 and 40.8±19.1 days, respectively. Furthermore, the total cost of patients without any hospital 
infection was 2451±3098 USD (83 674 480±105 765 500 Rials). On the other hand, the cost for infected patients was 3264±6078 USD   
(207 497 500±111 430 700 Rials). 
   Conclusion: Hospital-acquired infections can impose great costs on both patients and the health system. The results of this study 
indicated the importance of taking specific measures for infection control in hospitals. 
Keywords: Hospital-acquired infection, Hospital costs, Medical records, Iran 
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Introduction 
Hospitals are considered as the most important entities 
in provision of health services. However, these services 
may not be equally delivered to the public(1). Small area 
variation (SAV) analysis is a tool adopted by health ser-
vices researchers to define how rates of health care usage 
and events differ depending on various geographic areas. 
On the other hand, such services need to be of high quality 
and away from any kind of hospital side effects or infec-
tions (2,3). Prevention of hospital-acquired infections with 
respect to health, economic, and social aspects has caught 
the attention of experts for years; and they have been try-
ing tirelessly to find proper solutions for solving this  
problem (4). Luckily, these infections are, to a large ex-
tent, preventable (5). For instance, in case of England’s 
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context, approximately one third of these infections are 
likely to be preventable; such a reduction could save al-
most £150 000 000 for National Health Service (6). None-
theless, such infections impose high costs on public health 
systems. However, an exact estimation of costs caused by 
health-acquired infections requires an assessment of effi-
ciency of other infection control actions, which is usually 
difficult. 
Even if hospital mangers implement the required actions 
to reduce the costs, they still cannot control all the costs. It 
seems that less use of resources is the only choice left for 
decreasing such costs in hospitals. On the surface, reduc-
ing nosocomial infections is one of the proven methods 
for decreasing the use of resources. On the other hand, 
fewer infections would improve patients’ health condi-
tions as well (7). 
In most of the health systems, such as hospitals, rehabil-
itation centers, and long-term care centers, health care-
associated infections  have been a hidden and cross-
sectional issue; and no country or organization can claim 
that they have entirely solved it (8, 9).  Because these in-
fections are considered to be contagious and no patient, 
hospital, or health system is immunized against them, they 
impose considerable costs on these entities (10). 
Nosocomial infections are important for the following 
reasons: mortality and sickness of patients, increased 
length of hospital stay, and increased hospital costs due to 
long length of stay and extra therapeutic-diagnostic ser-
vices (11, 12). Hospital infections have affected millions 
of people around the world and are considered as one of 
the most important issues related to patient safety. They 
account for almost 5% to 10% of acute care admissions in 
industrial countries. The incidence rate of such infections 
rises up to 2 to 20 times for developing countries, and the 
rate of patients with such infections is 25% more (13). 
According to international studies, the prevalence of 
health care-associated infection (HCAI) for patients living 
in high-income countries is approximately 7.6%. Moreo-
ver, European Center for Disease Prevention and Control 
(ECDC) has estimated that annually about 4 131 000 pa-
tients get 4544.100 episodes of health care-associated in-
fections in Europe. In 2002, about 4.5% of people in the 
U.S. had HCAI, which is 9.3 infections per 1000 patient–
day.  The systematic review of the literature showed no 
clear picture of HCAI load in developing countries. There 
was only some general information in some regions of the 
countries, and this information was not even accessible in 
66% of these countries. In such countries, the rate of 
HCAI was a lot higher than developed countries, as its 
incidence at hospital level was reported to be 10.1%, but 
the entire statistics of infection prevalence was reported to 
be 8.5% to 15.5% (14). 
Centers for Disease Prevention and Control around the 
world estimated that about 2 million people suffer from 
nosocomial infections annually and approximately 100 
000 are lost to these infections. Such infections impose 
$4.5 billion extra costs on health care systems yearly (15). 
According to WHO, intensive care units, along with or-
thopedic and surgical wards, have the highest prevalence 
rate of hospital infections (16). In the United States, the 
incidence of nosocomial infections is around 2 million per 
year, out of which 500 000 cases happen in intensive care 
units. This means that about one fourth of such infections 
take place in ICUs, indicating the importance of this ward 
in the matter of hospital infections (17). 
To date, there has been no strong study on nosocomial 
infection costs in the context of Iran; moreover, health 
authorities have not paid enough attention to this issue. 
Thus, this study was conducted to estimate the extra costs 
caused by such infections in hospitals.  The results of the 
present study will shed light on the importance of noso-





This retrospective cohort study was conducted in 2017 
in Tehran province, Iran. This study was approved by the 
Ethics Committee of Tehran University of Medical Sci-
ences, TUMS (ethics code: 9111119006-1).  Although 
samples were selected using census method, those medical 
records that were incomplete or out of reach were exclud-
ed from the study. Because there were very few hospitals 
with equipped intensive care units, we needed to select 
those hospitals that, firstly, had intensive care unit and, 
secondly, whose active beds were occupied. 
Considering the above-mentioned point, we selected 
Imam Khomeini hospital, which is the largest hospital in 
the country and in the Mediterranean area.  All medical 
records of patients hospitalized in this hospital in 2015 
were reviewed. Moreover, one of the other methods to 
compare nosocomial infection costs was to use the data 
gathered from several hospitals either in the national or 
regional level. Moreover, we calculated per capita cost 
through dividing the total hospital costs by the number of 
hospitalized patients.  
All hospitals may face with a phenomenon called “small 
area variation (SAV)” in delivering medical services; 
therefore, we can use the same logic for studying hospi-
tals, which consist of doctors and other medical staff.  
This perspective can be implemented and recommended. 
However, its implementation requires researchers to use 
precise and complicated statistical methods and great deal 
of time and financial resources due to the difference in 
data collection techniques and quality of hospital services 
and the difference in the admission policies of hospitals. 
Thus, it was decided to use the data of only 1 hospital to 
extract nosocomial costs in intensive care units, and this 
approach was by no means impeccable. 
One of the drawbacks of such approach is that the data 
gathered from only 1 hospital can result in bias. In other 
words, those patients who refer to that certain hospital 
may have referred for a common medical reason or prob-
lem, so we have the same risk factors for all of them; and 
if they are studied, the external validity of the study will 
weaken and the generalizability of the results will be af-
fected as well. Therefore, considering the problems asso-
ciated with both approaches and the limitations of the 
study, we decided to use data of only 1 hospital. However, 
we tried to reduce the problems which normally occur 
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during the data collection process, so we could have the 
least bias in the study. As mentioned by other studies, the 
severity and treatment of the diseases are 2 factors that 
increase nosocomial costs in intensive care units. Howev-
er, we needed a strategy to match patients using their fi-
nancial and clinical data to maintain a balance between 
case and control groups, select the control group accurate-
ly, and exclude patients with vague and unmatchable crite-
ria and indexes. Patients were studied for their medical 
costs, length of hospital stay, severity of their disease, and 
presence or non-presence of hospital infection. Most of 
the related studies have focused on ICU patients who pre-
sent a group of patients with exceedingly high severity 
and hospital cost. Furthermore, the costs of providing care 
for patients with nosocomial infections were compared 
with the costs of providing medical services for those 
without any sign of infection.  
We needed to study the case group before the control 
group. To this end, the list of all patients with nosocomial 
infection was extracted from the hospital infection record 
system. Then, using medical record number, name, age of 
the patient, and their hospitalized ward, their records were 
extracted from the medical record department of the hos-
pital. Next, cases of infection, hospital bill, lab infor-
mation, and the ward where the patient was hospitalized 
and ICU checklists were carefully studied. An ICU nurse 
was asked to extract data related to vital signs and other 
points listed in APACHE.  
From 189 medical records taken from the hospital’s 
medical record department, 90 were complete and useful 
for the objective of the study. Other medical records were 
excluded due to having incomplete information about 
hospital bill and not including all patients’ lab and other 
medical reports. In the second step, a control group was 
selected for the study. To choose the patients of this 
group, information of patients who were hospitalized in 
the general intensive care unit of the hospital in 2013 was 
obtained from the medical record department of the hospi-
tal. These data had to be adjusted; patients with less than 
48-hour hospitalization were excluded from the study, as 
they could not get any hospital infection. Then, the pa-
tients who were hospitalized in the same unit and had 
hospital infection were ruled out because they had been 
considered once before in the study.  Next, we asked for 
other remaining medical records from the medical record 
department of the hospital for both the case and control 
groups.  Out of 483 medical records, 145 were reviewed.   
 
Statistical analysis  
Data for both groups were entered into Excel software 
and analyzed using SPSS and STATA software. We also 




No significant relationship was found between age and 
gender with the incidence of nosocomial infection.  On the 
other hand, the chance of nosocomial infection was most 
affected by length of hospital stay and costs paid by pa-
tients (Table 1). In other words, the more the length of 
hospital stay in ICU and the more the hospital costs of 
patients, the more the chance of getting hospital infection 
(Table 1). 
Data analyzed using chi-square test revealed no correla-
tion between nosocomial infection with age and severity 
of disease as risk factors (p>0.005, odds ratio>1). Howev-
er, a significant relationship was found between nosocom-
ial infection with length of stay in ICU (p<0.005, odds 
ratio>1) (Table 2). 
Based on the findings of univariate and multivariate re-
gression, there was no significant correlation among vari-
ables of age, gender, and severity of disease with noso-
comial infection (p>0.005, Odds Ratio>1). On the contra-
ry, hospitalization of patients in ICU had a significant 
correlation with having nosocomial infection (p<0.005, 
Odds Ratio>1). Patients with longer length of hospitaliza-
tion were infected 1.12 times more than other patients 
although having the same severity of disease. 
In addition, the results of logistic regression indicated 
that severity of disease affects the incidence of any kind of 
hospital infection.  Patients with longer ICU stay were 
1.22 times more likely to get hospital infection despite 
having the same severity of disease.  
Moreover, logistic regression model was applied to de-
termine the effect of APACHE and total length of stay 
variables. Results showed that total length of stay had a 
significant effect on getting nosocomial infection. In other 
words, total length of stay for the infected patients was 
 
Table 1. Background variables along with important outcomes of hospitalized patients by their incidence of nosocomial infection 
Variable Patients with HAI 
(N=90) 
Patients without HAI 
(N=145) 





Age (year) 56.4±20.8 55.8±19.4 56.1±19.9 T=0.23 0.82 
 Gender (male)  53(58.9%) 79(54.5%) 132(56.2%) Chi2 =0.44 0.51 
Total length of 
stay (day)  
35.9 ±22.8 11.0±9.8 20.6±20.1 T=9.8** <0.001 
ICU length of 
stay (day)  
27.5±22.4 6.0±5.7 14.2±17.9 T=8.92 <0.001 
Dead cases 38(42.2%) 83(57.2%) 121(51.5%) Chi2=5.01* 0.03 
APACHE 
Score 



















*P<0.05      **P<0.01 
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1.12 times more than the non-infected (Table 3). 
 
Hospital-acquired infection and increased length of 
hospital stay 
Using regression analysis, it was concluded that having 
nosocomial infection increases the length of hospital stay 
up to 25 days. Our results indicated that mean±SD length 
of hospital stay for infected and non-infected patients was 
15.8±17.2 and 40.8±19.1, respectively. 
 
Hospital-acquired infection and increased costs of in-
fected patients 
STATA software was used to find the relationship be-
tween having nosocomial infection and increased costs of 
infected patients and to clarify to what extent it increases 
these costs. Our results showed that the total cost of pa-
tients without hospital infection was 2451±3098 USD (83 
674 480 ±105 765 500 Rials). On the other hand, the cost 
for infected patients was 3264 ±6078 USD (207 497 500 
±111 430 700 Rials). Therefore, on average, nosocomial 
infection increases the total cost of patients up to 3627 
USD (123 823 000 Rials). 
 
Relationship between total and capitation charges 
with severity of disease 
Considering the results of regression model using 
STATA software, it was concluded that capitation charges 
had no statistically significant correlation with the severity 
of disease and its indicator (APACHE score).  
 
Discussion  
According to the findings of the present study, there was 
a significant difference between studied variables (except 
for age, gender, and severity of disease before hospitaliza-
tion in ICU) and presence or non-presence of nosocomial 
infection. In other words, our results indicated that age, 
gender, and severity of disease (measured by APACHE 
score) had no effect on incidence of nosocomial infection. 
On the other hand, as the confounding effects of such var-
iables were controlled by the researchers, the results of 
this study are statistically reliable. Despite the findings of 
our study, Askarian et al. indicated that gender can be a 
risk factor for incidence of hospital-acquired infection, 
meaning that gender can both decrease or increase the risk 
of such infections (17). Also, age has been mentioned as a 
factor that independently increases the risk of nosocomial 
infection among hospitalized patients (18). 
Moreover, the difference between the total length of 
stay and ICU length of stay as well as the total costs and 
capitation costs of patients was more significant between 
case and control groups compared to number of deaths 
between these groups (Table 1). Therefore, the total length 
of stay, ICU length of stay, and total costs and capitation 
charges for infected patients were more than those of non-
infected ones. Furthermore, there was an important find-
ing in this table showing that number of deaths in the con-
trol group was more than the case group. Although other 
studies have shown that incidence of nosocomial infection 
relatively increases the number of deaths among infected 
patients (19, 20), our study results were quite the opposite. 
However, one study supported our results regarding the 
number of deaths among the infected patients. In that 
study, the incidence of nosocomial infections did not in-
crease the risk of deaths among the infected patients. 
However, they did not consider all kinds of infections, 
except blood stream infections. Their results indicated that 
incidence of blood stream infections did not increase the 
risk of death among the infected patients (16,21). One 
reason behind this can lie in paying more attention to and 
taking more care of infected patients by their families and 
the medical staff due to their condition. In other words, 
incidence of nosocomial infections puts them in the center 
Table 2. Risk factors for nosocomial infections 
Variable Category Patients with HAI 
(N=90) 





Gender(male)  37/53 66/79 0.84(0.49-1.42) 0.51 
Age group (year) 0-19 5(45.5%) 6(54.5%) 1(---) --- 
20-39 14(37.8%) 23(62.2%) 0.73(0.19-2.85) 0.65 
40-64 35(35%) 65(65%) 0.65(0.18-2.27) 0.50 




0-20 5(100%) 0(0%) 1(---) --- 
21-40 25(83.3%) 5(16.7%) 1.80(0.18-17.75) 0.61 
41-60 50(60.2%) 33(39.8%) 3.0(0.33-26.92) 0.33 
61-80 39(46.4%) 45(53.6%) 3.85(0.43-34.68) 0.23 
81-110 26(78.8%) 7(21.2%) 3.85(0.42-35.6) 0.24 
 
 
Length of stay (day) 
1-7 1(1.5%) 68(98.5%) 1(---) --- 
8-14 11(19.6%) 45(80.4%) 16.6(2.1-133.3)** 0.008 
15-28 24(53.3%) 21(46.7%) 77.7(9.9-169.4)** <0.001 
29-42 28(77.8%) 8(22.2%) 238(28.4-1992.6)** <0.001 
>6 Weeks 26(89.7%) 3(10.3%) 589.3(58.6-5924.5)** <0.001 
**P-value<0.01 
Table 3. Risk factors for each type of hospital-acquired infections 
 
Variable type 
Univariate model Multivariate model 
OR (CI=95%) P-value OR (CI=95%) p 
Age 1.002(0.99-1.02) 0.82 --- --- 
Gender 1.20(07-2.04) 0.51 --- --- 
APACHE Score 1.01(0.99-1.03) 0.14 --- --- 
Total length of stay 1.12(1.09-1.15) <0.001 1.12(1.09-1.15) <0.001 
ICU Length of stay 1.22(1.15- <0.001 --- --- 
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of attention. The other reason is that when they are infect-
ed, they are either discharged from the hospital (either by 
doctors’ order or self-discharged) or transferred to another 
hospital.   
The number of patients who are hospitalized for a week 
or fewer days is more than those who stay more than 1 
week in the hospital. To control the effect of this factor on 
the results of the study, patients with fewer days of hospi-
tal stay were divided into more subgroups.  Overall, the 
variable of length of hospital stay was divided into 5 
groups. The first 2 groups had stayed in the hospital for 1 
week, the second 2 groups stayed for 2 weeks, and the last 
group stayed more than 6 weeks. Considering the length 
of hospital stay, we can indicate that only this variable 
was significantly different between the case and control 
groups. The case group had stayed in the hospital more 
than the control group, and the incidence of nosocomial 
infection could prolong the length of hospital stay among 
the infected patients (P-value<0.005, Odds Ratio>1). Alt-
hough it is concluded that the incidence of nosocomial 
infection can prolong the length of hospital stay, the factor 
of time is also important.  It is of significant importance to 
know which of the variables of incidence of hospital in-
fection or length of hospital stay occurs sooner in terms of 
time, and this can affect our final judgment.  
According to the findings of our study, hospital stay, 
ICU length of stay, and severity of disease at the time of 
admission to the hospital or ICU were statistically signifi-
cant factors for incidence of nosocomial infection. How-
ever, the odds ratio of these variables could not be statisti-
cally dependable. Multivariate regression analysis showed 
that the more the severity of patients’ disease at the ad-
mission time and the more their length of hospital stay, the 
more the possibility of incidence of nosocomial infection.  
Our results revealed that between length of hospital stay 
and severity of disease, only the former had a significant 
correlation with incidence risk of hospital-acquired infec-
tion. This shows that the longer the patients stay in the 
hospital, the more they are in risk of acquiring nosocomial 
infection. 
In response to the question of “How much nosocomial 
infection can, on average, augment length of hospital 
stay?” Our results indicated that the non-infected patients 
had stayed 15.8±17.2 days in the hospital, while the in-
fected patients had spent 40.8±19.1 days in the hospital. 
Thus, on average, nosocomial infection had increased 
length of hospital stay up to 25 days. Nevertheless, if we 
analyze the regression results between incidence of noso-
comial infection (as an independent variable) and length 
of hospital stay, the regression coefficient for incidence of 
nosocomial infection would be 25. This is a crude beta-
coefficient, but its standardized coefficient is 0.49 
(p<0.001). This small standardized coefficient shows a 
strong relationship, indicating that incidence of nosocomi-
al infection boosts length of stay up to 25 days. This is a 
mutual relationship, as nosocomial infection increases the 
length of hospital stay and increased hospital stay raises 
the risk of getting nosocomial infection.  
Adding variables of age, gender, and even APACHE 
score does not affect the beta-coefficient of nosocomial 
infection. Therefore, the correlation between nosocomial 
infections and increased length of stay is not influenced by 
age, gender, and APACHE score. In other words, inci-
dence of hospital infection independently raises the length 
of hospital stay without being affected by those back-
ground variables. There have been some findings by other 
studies in support of our study results regarding the effect 
of nosocomial infection on increased length of hospital 
stay (22, 23). Moreover, in most studies, the number of 
days added to the patients’ hospital stay varied from 3 to 
28 days (24-27). Our findings showed that nosocomial 
infection increases hospital stay up to 25 days. 
 
Conclusion 
As found by the present study, some extra cost (3627 
USD) (123 823 000 Rials) was imposed on patients due to 
incidence of hospital infection. One of the drawbacks of 
Iran’s health system, which can also be found in other 
health systems of developing countries, is that although 
calculation of unit cost of health services is a difficult job, 
there is no serious effort and commitment to do it.  If the 
unit cost of health services was available in Iran, we 
would have been able to calculate the costs of many dis-
eases, and the results of these calculations would have 
been used in health policy and decision-making. Unfortu-
nately, due to not having these data in the country, no 
study has been able to calculate the extra costs of noso-
comial infections; therefore, the results of the present 




-Inaccessibility to medical records of some of the ICU 
patients  
- Inaccessibility to the medical data of some of general 
ICU patients  
 
Recommendations 
Considering the results of the present study, future re-
searchers should focus on the following topics: 
-Studying the direct and indirect effects of hospital in-
fections on patients and the society 
-Studying the mental, economic, and physical effects of 
hospital infections on hospital staff 
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